ACARIX AB
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauri… Read more
ACARIX AB (7AC) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ACARIX AB (7AC) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ACARIX AB - Net Assets Trend (None–None)
This chart illustrates how ACARIX AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ACARIX AB (None–None)
The table below shows the annual net assets of ACARIX AB from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ACARIX AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ACARIX AB Competitors by Market Cap
The table below lists competitors of ACARIX AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GWR Group Ltd
AU:GWR
|
$20.80 Million |
|
Konya Kagit Sanayi ve Ticaret AS
IS:KONKA
|
$20.80 Million |
|
Enogia SAS
PA:ALENO
|
$20.81 Million |
|
Innometry Co. Ltd
KQ:302430
|
$20.81 Million |
|
Hyungkuk F&B Co Ltd
KQ:189980
|
$20.79 Million |
|
GenSight Biologics S.A
PINK:GSGTF
|
$20.78 Million |
|
Awea Mechantronic Co Ltd
TW:1530
|
$20.78 Million |
|
Companhiade Eletricidade do Estado da Bahia - COELBA
SA:CEEB3
|
$20.78 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ACARIX AB's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ACARIX AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ACARIX AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ACARIX AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ACARIX AB (7AC) | €- | N/A | N/A | $20.79 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.30 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $42.41 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.72 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $620.14 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |